A. Fizazi, C. Serrand, A. Evrard, B. Bergeret, P.-E. Stoebner, and M. Marque, “High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors”, Acta Derm Venereol, vol. 104, p. adv40913, Nov. 2024.